Powerful Medical’s Queen of Hearts AI ECG model received FDA De Novo authorization in September 2026. What it detects, the registry results on false cath lab alarms, and what it…
An FDA-authorized AI can estimate five-year breast-cancer risk from a mammogram you already had. The harder test is turning prediction into appropriate, completed care.
AI can identify clinical-trial candidates faster. The harder test is whether patients are contacted, enrolled, and able to complete the journey.
Biohub and its partners are investing $1.8 billion in virtual-cell research. Here is what AI can simulate today, what still requires a laboratory, and how discovery loops could change medicine.
AI can spot a suspicious lung nodule. The harder question is whether the health system can carry the patient from that signal to completed care.
A large liver-cancer study shows what happened after an AI system found overlooked lesions: reports changed, cases escalated, and care pathways moved—without yet proving better patient outcomes.
A Mayo Clinic model may make elite medical reasoning available far beyond Rochester. But an answer is not the same thing as care—and an API cannot reorganize a hospital by…
HealthBench is becoming one of medical AI’s most influential scoreboards. Here is how physicians built it, what its model-versus-doctor results mean, and why a high score is not the same…
The FDA and CMS are testing a new bridge from AI-enabled chronic-care technology to Medicare payment, real-world evidence, and measurable patient outcomes. The promise is real. The proof is not…
A new emergency-department study shows where healthcare AI can matter: not simply spotting a signal, but helping a care team contact the patient and complete the next step.
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.